Skill Guide

Good Machine Learning Practice (GMLP) principles and application to clinical contexts

Good Machine Learning Practice (GMLP) is a set of risk-based, lifecycle-oriented principles ensuring ML/AI medical devices are safe, effective, and ethically developed, validated, and monitored within clinical workflows.

GMLP principles directly mitigate regulatory risk and patient harm, accelerating market clearance and fostering clinician trust in AI-driven diagnostics and treatment support systems. They are a prerequisite for sustainable, scalable commercial deployment of AI in healthcare.

1 Careers

1 Categories

8.8 Avg Demand

15% Avg AI Risk

How to Learn Good Machine Learning Practice (GMLP) principles and application to clinical contexts

Focus on understanding the foundational tenets: 1) Multi-disciplinary human oversight throughout the ML lifecycle. 2) The importance of well-characterized, representative clinical training data. 3) Basic concepts of algorithmic robustness, transparency (XAI), and performance monitoring post-deployment.

Apply GMLP to the full SaMD (Software as a Medical Device) lifecycle. Practice developing a risk management file (ISO 14971) for an ML model. Understand common pitfalls: data drift, confounding variables in clinical datasets, and the limitations of retrospective validation. Begin integrating with IEC 62304 for software lifecycle processes.

Master the integration of GMLP into organizational Quality Management Systems (QMS). Architect scalable MLOps pipelines with built-in validation gates and audit trails for regulatory submission. Lead cross-functional teams (clinicians, data scientists, regulatory affairs, legal) to align model development with unmet clinical needs and post-market surveillance requirements.

Practice Projects

Beginner

Case Study/Exercise

GMLP Audit of a Publicly Available Clinical AI Model

Scenario

You are given a published research paper describing an AI model for detecting diabetic retinopathy from fundus images. Your task is to conduct a preliminary GMLP compliance gap analysis.

How to Execute

1. Review the 'Methods' section for data provenance, size, diversity, and annotation protocols. 2. Evaluate the model's performance metrics (sensitivity, specificity) for potential bias across subpopulations (age, ethnicity). 3. Examine the discussion for mentions of model limitations, intended use environment, and any planned post-deployment monitoring. 4. Draft a 1-page report highlighting strengths, weaknesses, and key questions for the model developers regarding GMLP principles.

Intermediate

Project

Develop a GMLP-Compliant Model Development & Validation Protocol

Scenario

Your team is building an ML-based triage tool for chest X-rays in an emergency department. Draft the core sections of the technical file for regulatory strategy.

How to Execute

1. Define the Intended Use Statement and User Profile precisely. 2. Create a risk analysis matrix (ISO 14971) identifying potential harms (e.g., false negative missing pneumonia, algorithmic bias affecting specific patient groups). 3. Specify the clinical data management plan, including sources, inclusion/exclusion criteria, and ground truth establishment (adjudication). 4. Design the validation protocol: hold-out test set creation, primary and secondary performance metrics, and predefined acceptance criteria for clinical utility.

Advanced

Project

Architect a GMLP-Compliant MLOps Pipeline for a SaMD Product

Scenario

As the technical lead, you are responsible for designing the automated pipeline that will support continuous learning and version control for a cleared AI-powered pathology tool, ensuring it remains in a state of regulatory control.

How to Execute

1. Design a version-controlled pipeline with immutable data and model artifacts, including detailed provenance tracking. 2. Implement automated validation gates after each training run: performance on a frozen reference dataset, fairness metrics, and robustness checks (e.g., to common imaging artifacts). 3. Establish a Change Control Board (CCB) process, integrated into the pipeline, to approve and document model updates that trigger a potential re-submission or notification to authorities (e.g., FDA's PCCP). 4. Integrate continuous monitoring of real-world performance (RWD) and data drift into the production environment, with automated alerts and rollback capabilities.

Tools & Frameworks

Regulatory & Quality Frameworks

FDA's GMLP Principles (2021)IEC 62304 (Medical Device Software Lifecycle)ISO 14971 (Risk Management for Medical Devices)EU MDR Annex IIMDRF SaMD Guidance

These form the regulatory backbone. GMLP principles guide development; IEC 62304 and ISO 14971 provide the process requirements for software development and risk management. They are used to structure the technical file and quality system from design input to post-market surveillance.

Technical Execution & MLOps Tools

DVC (Data Version Control)MLflow (Experiments & Model Registry)Kubeflow / AWS SageMaker PipelinesGreat Expectations (Data Validation)TensorFlow Data Validation (TFDV)

Tools for implementing traceability and reproducibility, core GMLP tenets. DVC/MLflow track data and model experiments. Kubeflow/SageMaker orchestrate complex pipelines. Great Expectations/TFDV automate data quality checks, critical for ensuring training data integrity.

Explainability & Monitoring

SHAP (Shapley Additive Explanations)LIME (Local Interpretable Model-agnostic Explanations)Evidently AI (Data/Model Drift)Arize AI / Whylabs (Production Monitoring)

SHAP/LIME provide post-hoc explanations for model predictions, supporting transparency requirements. Evidently AI and production monitoring platforms are used to continuously track data drift and model performance decay in the live clinical environment, triggering re-evaluation cycles.

Interview Questions

Answer Strategy

The interviewer is assessing practical application of a core GMLP principle and awareness of real-world clinical data challenges. Structure your answer: 1) Define data quality in this context (relevance, integrity, representativeness). 2) Describe concrete steps (data provenance audits, multi-disciplinary label adjudication for sepsis ground truth, handling missingness). 3) Explicitly name pitfalls: a) Label leakage from future data (e.g., using post-diagnosis labs), b) Confounding by hospital workflow (e.g., vitals recorded more frequently for sicker patients), c) Bias from under-represented sub-populations (e.g., immunocompromised patients with atypical presentations).

Answer Strategy

Tests problem-solving under GMLP constraints and understanding of risk management. Frame your response: 1) Immediate risk mitigation (labeling the finding, restricting intended use). 2) Root cause analysis (data imbalance? image preprocessing differences?). 3) Long-term solution (data augmentation, model retraining). 4) Regulatory strategy impact (need to update intended use statement, possibly requiring a supplemental submission).